ACB's Q2 Earnings on Deck: International Medical Cannabis in Focus
Aurora Cannabis faces declining revenues in Q2 earnings, with international medical cannabis markets offsetting weakness from market exits and reimbursement cuts.· summarised by Stockedin
PAHC